The role that artificial intelligence (AI) and other technology can play in care delivery is growing, said Coral Omene, MD, ...

Cambridge: AstraZeneca has entered a strategic research collaboration with Shijiazhuang City-based CSPC Pharmaceuticals Group ...

Haywood Securities’ June 13 report argues that HealWELL AI is well-positioned to capitalize on its rapid growth ...

The potential therapy for idiopathic pulmonary fibrosis is notable because not only was the small molecule discovered by ...

Hospital for Special Surgery (HSS) presented a research study at the European Alliance of Associations for Rheumatology ...

Mohammed Sadhik Shaik, a researcher and IT specialist, is addressing this issue through ongoing work on Blockchain and ...

There are subtle but significant differences in the morphology and biochemistry of the eye between men and women. These differences may affect disease susceptibility, symptoms and progression, ...

Insulin resistance (IR) is a crucial factor in metabolic disorders like non-alcoholic fatty liver disease (NAFLD) and polycystic ovary syndrome (PCOS), ...

Friday’s deal with fits neatly within AstraZeneca’s business development strategy of upping investments in AI and in China.

Chemotherapy is a vital treatment for people with all forms of cancer. It's a process that uses drugs designed to kill, ...

Recent studies assessed artificial intelligence (AI) assistance tools in their ability to provide quality medical ...

AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which ...